Germany backs away from variable drug discount plan
Germany will drop a variable discount plan for branded drugs, Reuters reports, after pharmaceutical companies warned of investment cuts.
Kathrin Rezac takes over brand communications at Reviderm
Reviderm has appointed Kathrin Rezac as Team Lead Brand & Communications, strengthening its brand and corporate communications.
Comprix 2026: Scholz & Friends leads the winners list
The Comprix 2026 presented 31 awards in Cologne, with Scholz & Friends leading ahead of Peix Health Group and Mensch.
medac appoints Christian Matschke as COO
medac has appointed Dr. Christian Matschke as COO, with responsibility for production, quality, supply chain and cross-site operations.
Established medicines need renewed focus
Christopher Hähner of Good Healthcare Pharma says established medicines need active lifecycle management despite the industry’s innovation focus.
#OffenGesagt addresses chronic illness in working life
The Hertie Foundation’s #OffenGesagt campaign highlights chronic illness at work, focusing on communication, bias and practical support.
Bayer CEO Bill Anderson warns of Germany’s competitiveness gap
Bayer CEO Bill Anderson says high energy costs and bureaucracy put Germany at a disadvantage. He also warns of fertilizer risks linked to Hormuz disruptions.
Boehringer Ingelheim halts planned investment in Germany
Boehringer Ingelheim is halting €900 million in planned investment in Germany for 2027 to 2030, citing policy-related and location factors.
Patient-first disease language gains momentum in pharma
From mpox to obesity and PMOS, healthcare is revisiting disease language. The goal is less stigma, clearer diagnosis, and more patient-centered communication.
Sanofi picks Snowflake to scale AI across drug development
Sanofi is consolidating data on Snowflake and rolling out Cortex AI agents, starting with “Concierge for Field” to speed up sales visit preparation.